Abstract: The invention relates to a process for preparing a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a spray coating comprising a testosterone.
Type:
Application
Filed:
June 21, 2023
Publication date:
October 19, 2023
Applicant:
EB IP Hybritabs B.V.
Inventors:
Leonardus Gerardus Jozef DE LEEDE, Henderik Willem FRIJLINK, Mark WILLIAMS, Jan Johan Adriaan TUITEN, Anko Cornelus EISSENS
Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
Type:
Application
Filed:
April 6, 2021
Publication date:
September 23, 2021
Applicant:
EB IP HYBRITABS B.V.
Inventors:
Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede
Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
Type:
Grant
Filed:
August 25, 2017
Date of Patent:
April 6, 2021
Assignee:
EB IP HYBRITABS B.V.
Inventors:
Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede
Abstract: The invention relates to a process for preparing a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a spray coating comprising a testosterone.
Type:
Application
Filed:
May 23, 2017
Publication date:
October 1, 2020
Applicant:
EB IP Hybritabs B.V.
Inventors:
Leonardus Gerardus Jozef DE LEEDE, Henderik Willem FRIJLINK, Mark WILLIAMS, Jan Johan Adriaan TUITEN, Anko Cornelis EISSENS
Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
Type:
Application
Filed:
August 25, 2017
Publication date:
December 14, 2017
Applicant:
EB IP HYBRITABS B.V.
Inventors:
Johannes Martinus Maria BLOEMERS, Anko Cornelus EISSENS, Henderik Willem FRIJLINK, Leonardus Gerardus Jozef DE LEEDE
Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
Type:
Grant
Filed:
May 14, 2012
Date of Patent:
September 19, 2017
Assignee:
EB IP HYBRITABS B.V.
Inventors:
Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede